Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens
Cancer immunotherapy targets the interplay between immune and cancer cells. In particular, interactions between cytotoxic T lymphocytes (CTLs) and cancer cells, such as PD-1 (PDCD1) binding PD-L1 (CD274), are crucial for cancer cell clearance. However, immune checkpoint inhibitors targeting these in...
Main Authors: | Soorin Yim, Woochang Hwang, Namshik Han, Doheon Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.884561/full |
Similar Items
-
Integrated intra‐ and intercellular signaling knowledge for multicellular omics analysis
by: Dénes Türei, et al.
Published: (2021-03-01) -
Insights into intercellular receptor-ligand binding kinetics in cell communication
by: Chenyi An, et al.
Published: (2022-06-01) -
Flavivirus–Host Interaction Landscape Visualized through Genome-Wide CRISPR Screens
by: Aditi Kanojia, et al.
Published: (2022-09-01) -
How has CRISPR transformed therapeutic drug discovery?
by: Jade Parker
Published: (2023-03-01) -
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies
by: Minghua Xiang, et al.
Published: (2024-04-01)